Actively Recruiting

Phase Not Applicable
Age: 18Years - 99Years
MALE
NCT05989854

The Remote Study: Investigating the Effects or Online Exercise on Quality of Life in Men With Prostate Cancer

Led by University of Surrey · Updated on 2024-12-17

50

Participants Needed

1

Research Sites

60 weeks

Total Duration

On this page

Sponsors

U

University of Surrey

Lead Sponsor

R

Royal Surrey County Hospital NHS Foundation Trust

Collaborating Sponsor

AI-Summary

What this Trial Is About

Currently, there are few opportunities for patients with cancer to have individual exercise guidance, and this has further been impacted by the Covid-19 pandemic. However, during the pandemic the use of virtual/remote platforms has been crucial in delivering care to cancer patients. The investigators think that remote exercise training may also offer a solution to support positive change in prostate cancer patients. As a result, the investigators have developed a remote/online exercise programme to explore this further. This study will explore the effectiveness of an 8-week remote exercise and behavioural support intervention, and whether prostate cancer patients feel they benefit from this. The study also aims to see if this sort of exercise programme can be delivered to more prostate cancer patients in the future. This project is open to men with prostate cancer on long term hormone therapy. The intervention will be comprised of one remote supervised session per week, completed 1-1 using an online platform and up to two additional sessions, depending on its suitability for the patient, will be prescribed as unsupervised home-based exercise.

CONDITIONS

Official Title

The Remote Study: Investigating the Effects or Online Exercise on Quality of Life in Men With Prostate Cancer

Who Can Participate

Age: 18Years - 99Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Have had an orchiectomy OR are receiving a GnRH agonist/antagonist OR are currently receiving Abiraterone, Enzalutamide, Apalutamide, or Darolutamide
  • Plan to remain on the above treatments for at least the next 6 months
  • Male
  • Aged between 18 and 99 years
Not Eligible

You will not qualify if you...

  • Currently receiving chemotherapy or radiation therapy (patients who start these treatments after joining can continue)
  • Classified as high risk for cardiovascular events
  • Have an acute illness or any musculoskeletal, cardiovascular, or neurological disorder that could make exercising unsafe
  • Have painful or unstable bony metastases

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Surrey

Guildford, Surrey, United Kingdom, GU2 7XH

Actively Recruiting

Loading map...

Research Team

R

Ralph Manders, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here